| Product NDC: | 11534-134 |
| Proprietary Name: | Senna and Docusate Sodium |
| Non Proprietary Name: | Senna and Docusate Sodium |
| Active Ingredient(s): | 50; 8.6 mg/1; mg/1 & nbsp; Senna and Docusate Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 11534-134 |
| Labeler Name: | Sunrise Pharmaceutical Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20070726 |
| Package NDC: | 11534-134-60 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (11534-134-60) |
| NDC Code | 11534-134-60 |
| Proprietary Name | Senna and Docusate Sodium |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (11534-134-60) |
| Product NDC | 11534-134 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Senna and Docusate Sodium |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070726 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Sunrise Pharmaceutical Inc |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES |
| Strength Number | 50; 8.6 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |